Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1651 AL 1665

Screening over Speech in Unselected Populations for Clinical Trials in AD (PROSPECT-AD): Study Design and Protocol

König A, Linz N, Baykara E, Tröger J, Ritchie C, Saunders S, Teipel S, Köhler S, Sánchez-Benavides G, Grau-Rivera O, Gispert JD, Palmqvist S, Tideman P, Hansson O.

J Prev Alzheimers Dis. 2023;10(2):314-321. doi: 10.14283/jpad.2023.11.

CD31 as a probable responding and gate-keeping protein of the blood-brain barrier and the risk of Alzheimer's disease

Zhang Z, Gan Q, Han J, Tao Q, Qiu WQ, Madri JA.

J Cereb Blood Flow Metab. 2023 Jul;43(7):1027-1041. doi: 10.1177/0271678X231170041. Epub 2023 Apr 12.

Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease

Xu Y, Jiang H, Zhu B, Cao M, Feng T, Sun Z, Du G, Zhao Z.

CNS Neurosci Ther. 2023 Aug;29(8):2060-2073. doi: 10.1111/cns.14238. Epub 2023 May 5.

Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer's Disease

Liu X, Liu Y, Liu Q.

Biosensors (Basel). 2023 Apr 30;13(5):515. doi: 10.3390/bios13050515.

Emerging concepts towards a translational framework in Alzheimer's disease

Cozachenco D, Zimmer ER, Lourenco MV.

Neurosci Biobehav Rev. 2023 Sep;152:105246. doi: 10.1016/j.neubiorev.2023.105246. Epub 2023 May 24.

Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease

Karima S, Aghamollaii V, Mahmoodi Baram S, Balenci L, Lanctôt KL, Kiss A, Tafakhori A, Mahdavi M, Rajaei S, Shateri S, Yarhoseini A, Mokhtari F, Fotouhi A, Riazi A.

J Alzheimers Dis. 2023;94(1):359-370. doi: 10.3233/JAD-221026.

Efficacy and safety of anti-amyloid-β monoclonal antibodies in current Alzheimer's disease phase III clinical trials: A systematic review and interactive web app-based meta-analysis

Jeremic D, Navarro-López JD, Jiménez-Díaz L.

Ageing Res Rev. 2023 Sep;90:102012. doi: 10.1016/j.arr.2023.102012. Epub 2023 Jul 7.

The Synergistic Potential of Combining PD-1/PD-L1 Immune Checkpoint Inhibitors with NOD2 Agonists in Alzheimer's Disease Treatment

Ghareghani M, Rivest S.

Int J Mol Sci. 2023 Jun 30;24(13):10905. doi: 10.3390/ijms241310905.

Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis

Gaur A, Rivet L, Mah E, Bawa KK, Gallagher D, Herrmann N, Lanctôt KL.

Ageing Res Rev. 2023 Nov;91:102046. doi: 10.1016/j.arr.2023.102046. Epub 2023 Aug 28.

Subcellular proteomics insights into Alzheimer's disease development

Liang Z, Zhuang H, Cao X, Ma G, Shen L.

Proteomics Clin Appl. 2024 May;18(3):e2200112. doi: 10.1002/prca.202200112. Epub 2023 Aug 31.

Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies

Alam JJ, Maruff P, Doctrow SR, Chu HM, Conway J, Gomperts SN, Teunissen C.

Neurology. 2023 Oct 24;101(17):e1708-e1717. doi: 10.1212/WNL.0000000000207755. Epub 2023 Sep 1.

Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS)

Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, Zeltzer E, Windon CC, Soleimani-Meigooni DN, Tanner JA, Heath CL, Lesman-Segev OH, Aisen P, Eloyan A, Lee HS, Hammers DB, Kirby K, Dage JL, Fagan A, Foroud T, Grinberg LT, Jack CR, Kramer J, Kukull WA, Murray ME, Nudelman K, Toga A, Vemuri P, Atri A, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Riddle M, Rogalski EJ, Salloway S, Sha S, Turner RS, Wingo TS, Wolk DA, Koeppe R, Iaccarino L, Dickerson BC, La Joie R, Rabinovici GD; LEADS Consortium.

Alzheimers Dement. 2023 Nov;19 Suppl 9(Suppl 9):S98-S114. doi: 10.1002/alz.13453. Epub 2023 Sep 10.

Unravelling of molecular biomarkers in synaptic plasticity of Alzheimer's disease: Critical role of the restoration of neuronal circuits

Pinky, Neha, Ali M, Tiwari P, Alam MM, Hattiwale HM, Jamal A, Parvez S.

Ageing Res Rev. 2023 Nov;91:102069. doi: 10.1016/j.arr.2023.102069. Epub 2023 Sep 9.

Anti-amyloid antibody treatments for Alzheimer's disease

Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.

Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias